OSGEPL1-AS1: A Drug Target / Disease Biomarker (G101409258)

Target Name: OSGEPL1-AS1

NCBI ID: G101409258

OSGEPL1-AS1

Other Name(s): OSGEPL1 antisense RNA 1

OSGEPL1-AS1: A Drug Target / Disease Biomarker

OSGEPL1-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the OSGEPL family, which includes several similar proteins that play a role in the regulation of stem cell proliferation and differentiation.

Recent studies have identified OSGEPL1-AS1 as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because the protein is involved in several cellular processes that are associated with the development and progression of these diseases.

One of the key functions of OSGEPL1-AS1 is its role in the regulation of stem cell proliferation. Stem cells are a type of cell that have the ability to develop into any type of cell in the body, and they play a key role in the development and repair of tissues. However, stem cells can also promote the formation of cancer, and OSGEPL1-AS1 has been shown to play a role in the regulation of stem cell proliferation and the development of cancer.

Studies have shown that OSGEPL1-AS1 is expressed in various tissues of the brain and that it is involved in the regulation of neuron growth and differentiation. This suggests that OSGEPL1-AS1 may be a potential drug target for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

OSGEPL1-AS1 is also involved in the regulation of inflammation, which is a key aspect of many diseases, including cancer and neurodegenerative diseases. Studies have shown that OSGEPL1-AS1 is involved in the regulation of the immune response and that it may play a role in the development and progression of autoimmune disorders.

In addition to its role in stem cell proliferation and inflammation, OSGEPL1-AS1 is also involved in the regulation of cell adhesion. This is the process by which cells stick together and form tissues, and it is a key aspect of many diseases, including cancer.

The identification of OSGEPL1-AS1 as a potential drug target or biomarker for several diseases makes it an important area of research for scientists. Further studies are needed to fully understand the role of OSGEPL1-AS1 in these diseases and to develop effective treatments.

Protein Name: OSGEPL1 Antisense RNA 1

The "OSGEPL1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OSGEPL1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets